Pharma’s focus on specialty care: The impact on HCP practice

These high-value drugs targeting complex or rare conditions are dominating today’s market, making up the majority of novel FDA drug approvals with new breakthroughs every year, along with a growing share of manufacturer revenue.

The expanding specialty market places increasing demands on physicians’ time, continuing education, and practice. This presentation will discuss these growing trends, including:

• Which “hot” therapeutic areas to keep an eye on
• How the role of primary care physicians in the growing specialty market is evolving
• Impact of specialization on HCP audiences

Speaker:

Tina Fresta, BA, MPH 

Medical Communication Strategist 

epocrates

Request Free!